Stocks Comparison
Myriad Genetics vs QuidelOrtho: revenue, profit, margins and growth compared
Myriad Genetics brought in $824.5M of revenue in fiscal 2025, QuidelOrtho $2.7B in fiscal 2025. Revenue changed by -1.6% at Myriad Genetics and -1.9% at QuidelOrtho on the year before, so Myriad Genetics grew faster. Myriad Genetics kept -44.4% of its revenue as net profit, QuidelOrtho -41.5%.
Side by side, latest fiscal year
| MYGN | QDEL | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 28, 2025) |
| Revenue | $824.5M | $2.7B |
| Revenue growth | -1.6% | -1.9% |
| Net income | -$365.9M | -$1.1B |
| Net margin | -44.4% | -41.5% |
| Free cash flow | n/a | -$83M |
| Free cash flow margin | n/a | -3.0% |
| Earnings per share (diluted) | -$3.95 | -$16.69 |
| Cash | $149.6M | $169.8M |
| Debt | $119.9M | $2.7B |
| Price to earnings | n/a | n/a |
| Market value | $398.9M | $750.2M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #159 of 523 · Health care | #90 of 523 · Health care |
Over the years
Questions about Myriad Genetics and QuidelOrtho
Which is bigger by revenue, Myriad Genetics or QuidelOrtho?
QuidelOrtho is bigger by revenue: $2.7B in fiscal 2025, against $824.5M for Myriad Genetics in fiscal 2025.
Which keeps more of its revenue as profit, Myriad Genetics or QuidelOrtho?
Myriad Genetics had a net margin of -44.4% in fiscal 2025; QuidelOrtho had -41.5% in fiscal 2025.
Which grew revenue faster, Myriad Genetics or QuidelOrtho?
In their latest fiscal years revenue changed by -1.6% at Myriad Genetics and -1.9% at QuidelOrtho.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.